Ignite Creation Date:
2024-05-06 @ 9:16 AM
Last Modification Date:
2024-10-26 @ 12:12 PM
Study NCT ID:
NCT02941926
Status:
COMPLETED
Last Update Posted:
2023-10-24
First Post:
2016-10-20
Brief Title:
Study to Assess the Safety and Efficacy of Ribociclib LEE011 in Combination With Letrozole for the Treatment of Men and PrePostmenopausal Women With HR HER2- aBC
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CLEE011A2404
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None